Crane Company Third Quarter 2026 Earnings Call - CRANE CO

Explicit Guidance:

• Full-Year 2026 Adjusted EPS: Raised by $0.35 per share (midpoint) to a range of $7.23 – $7.38.
• Acquisition Contribution to 2026 EPS: Expected contribution of approximately $0.30 per share (up from previous $0.20 guidance), driven by operating margin expansion of over 500 basis points this year.
• ROIC Hurdle: Expectation to achieve the 10% ROIC hurdle approximately 18 months earlier than originally anticipated due to acquisition performance.
• Aerospace & Advanced Technologies (AAT) Core Growth (FY 2026): Expected to be modestly above the high end of the long-term framework of 7–9%; leverage expected between 35% and 40%.
• Process Flow Technologies (PFT) Core Growth (Full Year 2026): Expects low single-digit core growth.
• Corporate Expenses (FY 2026): Expected to be within $80 – $85 million.
• Non-Operating Expense (FY 2026): Estimated at approximately $58 million.
• Effective Tax Rate (FY 2026): Estimated to approximate 23%.
• PSI (5-Year Target): Projected to grow from $60 million to $150 million EBITDA faster than originally planned; future growth expected at 4%–6% annually with leverage of 35%–40% after the three-year mark.

Business-Segment Outlook:

• Aerospace & Advanced Technologies (AAT):
  • Demand: Robust demand across commercial aerospace, defense, and space; missile defense, radar, advanced power conversion, and space-based capabilities remain prioritized.
  • Backlog: Record backlog of nearly $1.3 billion (up 9% core); program wins provide increasing visibility through the rest of the decade.
  • Commercial: Solid original equipment (OE) demand; aftermarket remains strong (up 11% YoY in core commercial aftermarket).
  • Acquisitions: Druck expected to continue outperforming; combined AAT and Druck business remains highly confident in full-year sales outlook.
• Process Flow Technologies (PFT):
  • Transformation: Continued shift toward higher-growth, higher-margin, less cyclical markets: cryogenics (space launch), pharmaceuticals (gOP1 capacity), water/wastewater, power, and nuclear.
  • Order Momentum: Core orders grew 20% YoY in Q3; backlog increased 8% core YoY and 2% sequentially.
  • Market Specifics:
    • Cryogenics: Strong traction in space launch infrastructure and general aerospace environmental testing.
    • Power: Momentum driven by U.S. natural gas expansion (combined cycle turbines).
    • Pharma: U.S. backlog growing due to reshoring and capacity expansion.
    • Water/Wastewater: U.S.-based business resilient; acquisition of Trillium Pumps strengthens position.
    • Chemical: Market expected to remain flat in Europe in 2027; U.S. and Middle East recovering. Crane expects to drive growth without depending on chemical recovery.
    • Nuclear: Growth driven by capacity expansion and project wins.
  • Margin: Adjusted operating margin expanded to record levels; core leverage estimated at 35%–40% range through cycles.
• Divestitures: Exit of non-residential construction exposure completed with the sale of Crane Supply in Canada and the UK business (BSNU). No further substantial divestitures currently planned.

Market and Competitive Outlook:

• Strategic Shift (PFT): Reduced reliance on chemical markets (down from 30% to ~20% of portfolio); increased exposure to water/wastewater (~15%), general industrial (~20%), and power/nuclear (~15%).
• Acquisition Strategy: Significant capacity to deploy capital; robust pipeline of opportunities.
  • Trillium Pumps: Pending acquisition expected to close near the end of Q1 2026, strengthening water/wastewater position.
  • BSNU (Building Services and Utilities): Announced investiture to sharpen strategic focus; roughly $160M revenue at fleet margin.
• Geographic Trends: U.S. is the best market overall; Europe flat; Middle East solid/recovering. PFT exposure to Middle East is <5%, with material impact not expected.
• Defense: Expecting 40%–50% growth in missile programs next year, with projections of 4x–6x growth off current 2026 base over the decade.

Macro / Industry Outlook:

• Economic Drivers: Commercial aerospace ramp and defense investment (resilient) driving growth.
• PFT Tailwinds: Space launch market growth, U.S. chemical feedstock advantages (natural gas), pharma reshoring, and water infrastructure investments.
• Chemical Cycle: Expected to remain flat in Europe into 2027; U.S. showing sporadic project activity; full recovery in P&L (construction/durable goods driven) not expected in H1 2027.
• FX: Neutral on FX impact; currency effects not cited as a primary headwind.
• Inflation/Pricing: Pricing power noted to be net of inflation; productivity improvements offsetting cost pressures.

Strategic Initiatives:

• M&A:
  • Trillium Pumps: Acquisition pending; expected to backfill dilution from BSNU investiture.
  • BSNU: Divestiture to sharpen focus; close timing aligned with Trillium acquisition.
  • Pipeline: Active pursuit of "fixer-upper" assets and high-growth businesses via the "Crane Business System" (CBS) integration capability.
• Capital Allocation: Strong balance sheet (pro forma net leverage 1.1x) enabling further M&A; significant capacity to deploy capital.
• Investor Relations: Next investor day scheduled for February 9, 2026, in New York City.

Risks and Headwinds to Outlook:

• Acquisition Dilution: BSNU (fleet margin) vs. Trillium (below fleet margin) transition may cause temporary dilution, though expected to be offset by Trillium contribution in the year of close.
• Chemical Market Volatility: While less dependent, potential slowdown in global chemical capacity could impact growth if U.S./Middle East recovery does not accelerate as expected.
• Geopolitical Risks: Ongoing Middle East conflict could cause shipment delays or freight cost increases, though exposure is minimal (<5%) and currently considered a manageable headwind.
• FX Fluctuations: Though neutral guidance is provided, global FX volatility remains a factor (isolated in non-GAAP reporting).
• Integration Risk: Continued success relies on executing the "Crane Business System" integration for future acquisitions to realize margin expansion.

Management Tone on the Future:

• Confidence: "Highly confident" in the outlook for 2026 and 2027; described as entering 2027 with "record backlog, strong momentum, increasing earnings power, and significant strategic flexibility."
• Execution: Repeated emphasis on "exceptional execution," "record margins," and the "Crane Business System" as a key differentiator.
• Momentum: Viewed as entering the "early innings" of value creation in the PFT transformation and "early innings" of the five-year PSI growth acceleration.
• Acquisition Success: Recent deals (PSI, Trillium, etc.) perceived as exceeding expectations, reinforcing the "well-oiled machine" culture.

Miscellaneous:

• Q3 2026 Context: Record backlog up 9% YoY; orders up 20% in PFT and 8% in AAT; adjusted operating margin 22.5% for the company (up 130 bps); $0.30 EPS contribution from acquisitions.
• Debt Repayment: $170 million of debt repaid in Q3, resulting in 1.1x pro forma net leverage.
• One-Time Items: Adjusted results exclude net benefit from IEPA tariff recoveries.